Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, openWorldHint and destructiveHint=false, so the safety profile is covered. The description adds genuinely useful non-annotation context — 'FREE beta' (cost/pricing) and compactness for token budgeting — but says nothing about rate limits, freshness, or the shape/size of what comes back.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two very short sentences with the pricing note front-loaded, no filler or redundancy. It is tersely efficient, though at the cost of the guidance an agent arguably needs.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema exists, but the tool is a simple two-parameter read whose annotations carry the safety profile. Missing sibling differentiation and the undocumented limit parameter keep it at minimum-viable rather than complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is only 50%: cik is documented, but limit (1-500) has no description in either schema or prose. The description adds nothing about parameter meaning, defaults, or how limit interacts with screening, so it fails to compensate for the coverage gap.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific resource (recent SEC filing metadata) and its character (compact, screening-oriented), so an agent knows it is a filing-listing tool. However, it never distinguishes itself from the sibling sec_recent_filings_evidence, leaving the basic/evidence split to be inferred.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The phrase 'optimized for low-token agent screening' implies when to reach for it (cheap first-pass triage), but there is no explicit when-to-use, no exclusions, and no pointer to the evidence sibling as the follow-up alternative.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.